GeneDx to Report Third Quarter 2026 Financial Results on Monday, November 9, 2026
Business Wire•23/10/2026•16:05 ET
0
Key Highlights
- ➤GeneDx (WGS) will report third-quarter 2026 results after market close November 9
- ➤Management will discuss third-quarter financial and operating results at 4:30 p.m. Eastern Time
- ➤GeneDx says its Infinity dataset is the world’s largest rare disease genomic dataset
GeneDx to Report Third Quarter 2026 Financial Results on Monday, November 9, 2026
GeneDx (Nasdaq: WGS), the leader in rare disease diagnosis and improving health through the power of genomic data, today announced it will release financial results for the third quarter of 2026 after the market closes on Monday, November 9, 2026. Management will host a conference call that day to discuss third quarter 2026 financial and operating results at 4:30 p.m. Eastern Time.
Get started
Create a free account to read the full story.